Neurodevelopmental Endpoints
Neurodevelopmental Endpoints is a construct in neurotoxic risk assessment that refers to specific, measurable indicators of structural, functional, or behavioral aspects of the developing nervous system used to evaluate the impact of toxicological exposures during critical periods of neurodevelopment.
278
Publications
19.8K
Citations
2.3K
Authors
658
Institutions
Publications per year
2017–2026
127
278
Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia.
Alan Lucas, Ruth Morley, Tim Cole · BMJ · 1988 · 684 citations · Full text
Medicine, Child Health, Pediatrics +17
David C. Bellinger, David Wypij, Adre duPlessis et al. · Journal of Thoracic and Cardiovascular Surgery · 2003 · 675 citations · Full text
Medicine, Cardiology, Pediatrics +16
1–5 of 278
2.3K
18
h-index
18
h-index
17
h-index
16
h-index
13
h-index
1–5 of 2.3K
658
RTI International
Durham, United States
28 h-index
66 publications
10.6K citations
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Bethesda, United States
23 h-index
814 publications
232.4K citations
Case Western Reserve University
Cleveland, United States
21 h-index
39 publications
10.3K citations
Emory University
Atlanta, United States
21 h-index
27 publications
4.4K citations
Stanford University
Stanford, United States
17 h-index
37 publications
5.7K citations
Women & Infants Hospital of Rhode Island
Providence, United States
16 h-index
28 publications
4.3K citations
Brown University
Providence, United States
16 h-index
29 publications
4.4K citations

University of Alabama at Birmingham
Birmingham, United States
16 h-index
40 publications
4.1K citations
1–8 of 658
35 publications · 5.4K citations
31
h-index
12 publications · 431 citations
12
h-index
11 publications · 524 citations
11
h-index
9 publications · 801 citations
9
h-index
8 publications · 214 citations
8
h-index
1–5